Introduction {#S1}
============

*Acinetobacter baumannii* infections used to be rare a few decades ago ([@B31]). However, its importance as an opportunistic human pathogen kept increasing and it is now responsible for a growing number of community and nosocomial infections including bacteremia, urinary tract infections, wound infections, meningitis, and pneumonia ([@B46]; [@B80]; [@B47]; [@B29]). It mainly affects compromised patients but it has also been identified as an important causative agent of infections in wounded military personnel ([@B54]; [@B58]; [@B5]). The success as an opportunistic pathogen, especially in hospital environments is due to its ability to resist desiccation and persist in the most diverse hospital locations combined with a growing resistance to disinfectants and major antibacterials ([@B36]; [@B14]; [@B57]; [@B54]; [@B65]; [@B24]). Furthermore, the problematic nature of *A. baumannii* infections is enhanced by its acquisition of resistance to carbapenems, which now exceed 90% in some geographical regions with a mortality rate of about 60% ([@B34]). Recent studies identified pathogenic and resistance islands ([@B25]; [@B69]; [@B59]; [@B41]) as well as several potential virulence factors ([@B29]) such as iron and other micronutrients uptake ([@B79]; [@B26]; [@B51]; [@B56]), motility ([@B52]; [@B21]; [@B77]), production of cytotoxic and protection factors ([@B68]; [@B37]), and adhesion and biofilm formation on abiotic and biotic surfaces ([@B27]; [@B45]).

We have described *A. baumannii* A118, a naturally competent isolate obtained from blood of an infected patient, that is susceptible to numerous antibiotics including those commonly used in molecular genetics ([@B63], [@B62]; [@B72]). We proposed that these characteristics make this strain a convenient experimental model studying the pathobiology of this relevant human pathogen. Accordingly, *A. baumannii* A118 has been used in numerous studies to assess the efficiency of metal/ionophore complexes to override aminoglycoside resistance ([@B44]), to understand the effect of serum albumin in competency stability ([@B74]; [@B61]) and acquisition of mobile genetic elements ([@B64]; [@B15]), the role of osmolarity in uptake of exogenous DNA ([@B16]), and in the discovery of a novel bacteriophage ([@B75]). The growing number of research groups utilizing *A. baumannii* A118 as model makes characterizing this strain in greater detail desirable. In this work we focus our analysis in characteristics associated to *Acinetobacter* pathogenicity and virulence.

Materials and Methods {#S2}
=====================

Bacterial Strains, Genomes, and Culture Conditions {#S2.SS1}
--------------------------------------------------

*Acinetobacter baumannii* A118 was isolated from the bloodstream of an infected patient in an intensive care unit ([@B49]; [@B63]). *Escherichia coli* TOP10 (Invitrogen, San Diego, CA, United States) was used as host in DNA recombinant cloning. *A. baumannii* ATCC 17978, ATCC 19606^T^ ([@B9]) and the isogenic ATCC 19606^T^ s1 (BasD^--^) and t6 (BauA^--^) derivatives ([@B18]) were used in bioassays to test acinetobactin production and utilization, respectively. Iron-rich and iron-limiting conditions were attained by supplementing the growth media with 100 μM FeCl~3~ or 100 μM 2,2′-dipyridyl (DIP), respectively.

The presence or absence of specific coding regions in the genome sequence of *A. baumannii* A118 (GenBank Accession Number [AEOW00000000](AEOW00000000)) ([@B62]) was determined using BLAST ([@B3]). BLASTp searches were performed with A minimum value of 30% amino acid identity, 70% coverage and a minimum *e*-value of 1 × 10^--5^. The reference genomes for sequence comparison were ATCC 17978 (Accession Number [CP000521](CP000521)), ATCC 19606 (Accession Number [ACQB00000000.1](ACQB00000000.1)), and ACICU (Accession Number [NC 010611](NC_010611)) ([Supplementary Table 1](#TS1){ref-type="supplementary-material"}). For K Locus and OC Locus sequence analysis, we used the most related genetic structures in GenBank Database ([Supplementary Table 1](#TS1){ref-type="supplementary-material"}).

Production and Utilization of Acinetobactin {#S2.SS2}
-------------------------------------------

Bioassays to test production or utilization of siderophore were carried out as previously ([@B18]). Briefly, supernatants from cultures using succinate medium were sterilized by filtration and spotted on filter disks placed on L agar plates containing 225 μM DIP seeded with the ATCC 19606^T^ t6 strain, which does not produce the acinetobactin receptor protein BauA. The plates were incubated for 24 h at 37°C, growth halos around the filters were an indication of production of a siderophore different from acinetobactin. The presence of the outer membrane protein BauA in *A. baumannii* strains was determined by western blotting with anti-BauA polyclonal antiserum using total lysates of bacterial cells cultured under iron-limiting or iron-rich conditions as described before ([@B18]). Briefly, total proteins from cells cultured under iron-rich or iron-limiting conditions were separated by SDS--PAGE using 12.5% polyacrylamide gels, transferred to a nitrocellulose membrane, and incubated in the presence of anti-BauA serum. The immunocomplexes were detected by chemiluminescence using HRP-labeled protein A ([@B18]).

Cell Motility and Biofilm Assays {#S2.SS3}
--------------------------------

Cell motility was assessed using semi-solid plates containing 0.3% agarose as described before ([@B52]). The plates were inoculated on the surface with bacteria using flat-ended sterile wooden sticks or depositing 0.003 ml of LB cultures grown to an OD~600~ of 0.3. Plates were incubated for 24 h at 24°C or 37°C in the dark or under blue light (emission peak centered at 462 nm) emitted by nine-LED (light-emitting diode) arrays with an intensity of 10 to 20 μmol photons/m^2^/s. Biofilms formed on the walls of polystyrene or glass tubes were stained with crystal violet, visually inspected and quantified after elution of the stain as previously described ([@B70]). The amount of biofilm formed by each sample was normalized to its total biomass, which was determined by measuring the OD~600~ of duplicate cultures as described before ([@B70]). Triplicate assays were done at least three times using fresh samples each time.

Infection Assays {#S2.SS4}
----------------

Randomly chosen *Galleria mellonella* larvae were injected with 1 × 10^5^ *A. baumannii* cells resuspended in sterile phosphate-buffered saline (PBS), or with PBS as negative control. After injection, the larvae were incubated at 37°C in the dark, and killing was assessed at 24-h intervals over 6 days. Caterpillars were considered dead and removed from the study if they displayed no response to probing. The results of the trial were omitted if more than two deaths occurred in the control groups. The experiments were repeated six times using 10 larvae per experimental group, and the resulting survival curves were plotted using the Kaplan-Meier method. *P-*values \< 0.05 are considered statistically significant.

Results and Discussion {#S3}
======================

*Acinetobacter baumannii* A118 is characterized for its susceptibility to a variety of antimicrobial agents such as ceftazidime, cefepime, piperacillin, minocycline, amikacin, gentamicin, sulfamethoxazole-trimethoprim, imipenem, meropenem, and ciprofloxacin ([@B63]). This characteristic makes it more suitable as a model for genetic analysis than most other isolates that exhibit multiresistance to antibiotics usually used for selection in a variety of techniques. To facilitate its use as model of infection we identify the presence of genes and functions previously associated with *A. baumannii* pathogenicity. The results discussed in this article are summarized in [Table 1](#T1){ref-type="table"}.

###### 

Characteristics of *A. baumannii* strains.

                                           ***A. baumannii***           
  ---------------------------------------- -------------------- ------- -------
  IUS -- Acinetobactin                     \+                   \+      \+
  IUS -- Baumannoferrin                    \+                   −       \+
  IUS -- Fimsbactin                        −                    −       \+
  Heme cluster 1                           \+                   \+      \+
  Heme cluster 2                           −                    −       −
  IUS -- FeoABC                            \+                   \+      \+
  Biofilm                                  \+                   −       \+
  Motility                                 \+                   −       \+
  Capsular polysaccharide -- locus K^1^    PSgc8                PSgc9   PSgc9
  Capsular polysaccharide -- locus OC^2^   New                  OCL1    OCL2

Plus signs denote functional systems.

1

According to the classification described in

Hu et al. (2013)

.

2

According to the classification described in

Kenyon et al. (2014)

.

Iron Uptake Systems (IUSs) {#S3.SS1}
--------------------------

A non-specific defense system of vertebrate animals against bacterial infection is the chelation of iron by high-affinity iron-binding proteins such as transferrin and lactoferrin ([@B11]). Consequently, bacteria have evolved very efficient iron-acquisition systems to scavenge iron from the iron-binding proteins of their hosts. These systems are varied and include synthesis of a siderophore (a high-affinity ferric iron chelator) that uptakes iron and mediates its internalization through a specific energy-dependent transport system ([@B11]; [@B13]; [@B43]), production of outer membrane receptors that recognize lactoferrin, transferrin, heme or non-indigenous siderophores ([@B40]; [@B4]; [@B13]; [@B33]), or direct binding and transport of ferrous iron ([@B42]). The siderophore-mediated iron uptake systems identified in *A. baumannii* strains are those that utilize acinetobactin ([@B19]; [@B2], [@B1]), baumannoferrin ([@B56]), or fimsbactins, which are represented by a family of six related chatechol/hydroxamate compounds ([@B60]). Since the acinetobactin system, originally described in the ATCC 19606^T^ strain ([@B18]; [@B50]), is the most widespread among *A. baumannii* isolates we identified the presence of the gene cluster as well as *entA* and *entB* orthologs, which code for functions required for the biosynthesis of the acinetobactin precursor 2,3-dihydroxybenzoic acid ([@B55]). We also carried out assays to identify the regulated expression of BauA, the outer membrane receptor of ferric-acinetobactin complexes ([Figure 1A](#F1){ref-type="fig"}), as well as the growth of *A. baumannii* A118 at increasing concentrations of DIP ([Figure 1B](#F1){ref-type="fig"}). The levels and iron regulation of BauA in *A. baumannii* A118 were similar to those in the control strains ATCC 19606^T^. Both strains showed higher production of this protein as compared to the levels detected in strain ATCC 17978 ([Figure 1A](#F1){ref-type="fig"}). However, comparison of growth of all three strains showed that while the OD~600~ levels reached by strains A118 and ATCC 17978 at increasing concentrations of DIP were nearly identical, strain ATCC 19606^T^ proved to be more sensitive to iron chelation, the growth of which was completely inhibited at a lower DIP concentration when compared with the two other tested strains ([Figure 1B](#F1){ref-type="fig"}). The *A. baumannii* ATCC 19606^T^ s1 mutant, deficient in production of acinetobactin due to lack of the biosynthetic enzyme BasD was inhibited at the lowest DIP concentration of all four strains tested ([Figure 1B](#F1){ref-type="fig"}). The ability of the strains A118 and ATCC 17978 to grow at higher DIP concentrations when compared to strain ATCC 19606^T^ could be due to the presence/expression of one or more additional iron acquisition systems or to a higher production of acinetobactin. It is known that *A. baumannii* ATCC 19606^T^ does not possess the genes coding for a fimsbactin siderophore and cannot express a functional baumanoferrin iron uptake system in spite of including the cognate gene cluster. This is supported by the observation that an ATCC 19606^T^ acinetobactin biosynthetic mutant cannot grow in the presence of DIP ([@B18]; [@B55], [@B56]). In addition to the acinetobactin gene cluster, *A. baumannii* ATCC 17978 includes the cluster coding for fimsbactin and baumannoferrin iron-uptake systems ([@B4]; [@B20]). Thus, the higher iron proficiency can be explained by the expression of one or both of these systems. Analysis of the *A. baumannii* A118 genome showed that it possesses the baumannoferrin gene cluster but not that one coding for a fimsbactin siderophore iron uptake system. To determine if besides the acinetobactin system, *A. baumannii* A118 expresses an additional iron uptake system we conducted a siderophore-utilization bioassays using the ATCC 19606^T^ t6 BauA-deficient strain, which cannot use acinetobactin to grow under iron-chelated conditions. [Table 2](#T2){ref-type="table"} shows that the *A. baumannii* ATCC 19606^T^ t6 BauA-deficient indicator strain was able to grow around the disks spotted with supernatants obtained from cultures of strains ATCC 17978 and A118 under iron-limiting conditions. These results strongly suggest that *A. baumannii* A118 secretes an additional siderophore that, given the presence the appropriate gene cluster, it most probably is baumannoferrin. However, further chemical assays are needed to prove that A118 produces baumanoferrin.

![Acinetobactin iron uptake system. **(A)** Synthesis and regulation of BauA. Total proteins from *A. baumannii* ATCC 19606^T^, ATCC 17978, and A118 cultured under iron-rich (100 μM FeCl~3~) and iron-limiting (100 μM DIP) conditions were separated on a 12.5% SDS--PAGE, transferred onto nitrocellulose, and probed with anti-BauA serum. The "Precision" molecular-mass protein markers (Bio-Rad) were detected with StrepTactin-HRP conjugate. The positions of the 50- and 75-kDa protein markers are shown on the left side to the gel. 19606, ATCC 19606^T^; 17978, ATCC 17978; Fe, iron-rich conditions; DIP, iron-limiting conditions. **(B)** Bacterial growth under iron limiting conditions. The strains were cultured overnight at 37°C in L broth containing increasing concentrations of the iron chelator DIP.](fmicb-10-01599-g001){#F1}

###### 

Siderophore utilization bioassays.

  **Crossfeeding sample**          **Halo around the filter disks (mm)**
  -------------------------------- ---------------------------------------
  H~2~O                            0
  FeCl~3~                          13.25 ± 0.96
  ATCC 19606^T^ Sp                 0
  ATCC 19606^T^ s1 (BasD^--^) Sp   0
  ATCC 17978 Sp                    15.75 ± 1.71
  A118 Sp                          13.75 ± 2.22

Strains to be tested were cultured in succinate medium for 24 h at 37°C. Culture supernatants (Sp), obtained by filter sterilization, were spotted onto filter disks that were placed on L agar plates containing 225 μM DIP and seeded with the reporter

A. baumannii

ATCC 19606

T

t6 strain deficient in the production of the BauA outer membrane acinetobactin receptor. Halos were measured after incubation for 24 h at 37°C. H

2

O or FeCl

3

were spotted as negative and positive controls, respectively.

A search for genetic determinants of a heme-acquisition system showed that *A. baumannii* A118 posseses the heme uptake cluster 2 ([@B4]). There is at least one report proposing that heme contributes to overcoming the iron limitation caused by the host's high affinity iron binding proteins ([@B12]). *A. baumannii* A118 also includes the *feoABC* genes, which code for the main bacterial Feo ferrous uptake system ([@B10]). The cluster specifies three proteins, FeoA of unknown function, the repressor FeoC, and FeoB that participates in translocation of iron across the inner membrane. A recent study showed that although the Feo system enhances growth in heat-inactivated human serum and contributes to resistance to human serum, it is not essential for virulence ([@B67]).

Biofilm Formation {#S3.SS2}
-----------------

The ability of *A. baumannii* strains to form biofilms on abiotic surfaces ([@B70]) is partially or totally responsible for their persistence in different environments such as the surface of medical devices and other common artifacts like furniture, linens, soap dispensers, phones and computer keyboards ([@B31], [@B30]; [@B53]; [@B76]; [@B7]; [@B23]). Comparative analysis of the *A. baumannii* A118 nucleotide sequence with *A. baumannii* genomes showed that the *csuA/BABCDE* chaperon-usher pilus assembly system is present in the A118 strain and the identities of the deduced amino acid sequence of the products of the cognate open reading frames is 96% or higher when compared to those from strain ATCC 17978. Standard crystal violet biofilm assays using polystyrene tubes showed that *A. baumannii* A118 formed a distinctive biofilm ring on the surface of the tubes as it was described for ATCC 19606^T^ cells ([@B70]). Control assays showed a stronger ring in the case of the strain ATCC 19606^T^ while significantly reduced biofilm was formed by strain ATCC 17978. Quantification of total biofilms formed on polystyrene and glass showed that strain A118 produced a significant amount of biofilm on glass and polystyrene surfaces ([Figure 2](#F2){ref-type="fig"}). It was of interest that while the biofilm mass was higher for strain A118 than for strain ATCC 19606^T^ on glass, the opposite was true for biofilm formed on plastic ([Figure 2](#F2){ref-type="fig"}). Although the molecular and cellular bases of these differences are unknown, variations in the amount of biofilms formed by different strains on the same or different types of surfaces seem to be a common property among *A. baumannii* clinical isolates ([@B48]; [@B66]; [@B61]; [@B77]).

![Production of biofilm. Quantification of biofilm formation on polystyrene and glass tubes by *A. baumannii* strains ATCC 19606^T^, ATCC 17978, and A118 after static incubation at 37°C. Quantification was carried out as described in "Materials and Methods."](fmicb-10-01599-g002){#F2}

Motility {#S3.SS3}
--------

*Acinetobacter baumannii* lacks flagellum and therefore cannot show flagellum-mediated swimming motility ([@B71]). However, it has been shown that *Acinetobacter* strains are capable of motility on semi-solid agar ([@B6]; [@B52]; [@B20]; [@B61]; [@B77]), and the movement is dependent on the concentration of iron in the environment and possibly on other stress related factors ([@B20]; [@B61]; [@B77]). Furthermore, it has been shown that at 24°C strain ATCC 17978 shows low or no signs of motility when growing exposed to light but this situation is reversed when growing in the dark ([@B52]; [Figure 3](#F3){ref-type="fig"}). This regulation depends on the expression of BlsA, a photoreceptor and transcriptional regulator ([@B52]), and the newly identified PrpABCD type I pilus assembly system ([@B77]). In contrast, as it was shown before, ATCC 17978 cells displayed comparable surface motility independently of illumination when cultured at 37°C ([@B52]). Analysis of *A. baumannii* A118 showed that this strain was unable to exhibit motility under blue light at 24°C but it showed slight motility in the dark ([Figure 3](#F3){ref-type="fig"}). This motility was more evident at 37°C in the dark although cells displayed a reduced motility when cultured at this temperature under illumination ([Figure 3](#F3){ref-type="fig"}). *A. baumannii* ATCC 19606^T^ did not show motility in any of the assayed conditions ([Figure 3](#F3){ref-type="fig"}). Analysis of the *A. baumannii* A118 genome showed the presence of all the genes associated with a type IV pilus system (T4P), known to play a role in *A. baumannii* twitching motility and surface-associated. Taken together, these results indicate that *A. baumannii* A118 is motile under the right conditions and that light and temperature affect the motility responses of different *A. baumannii* strains by mechanisms that remain to characterized.

![Surface motility on a semi-solid surface. Cells were inoculated on the surface of motility plates and incubated overnight at 24°C or 37°C in the dark or under blue light.](fmicb-10-01599-g003){#F3}

Locus K and Locus OC {#S3.SS4}
--------------------

*Acinetobacter baumannii* strains produce a capsular polysaccharide coded for by a gene cluster known as K locus, which exhibits sequence variations among isolates ([@B38]). Another surface polysaccharide produced by this bacterium is part of the lipooligosaccharide formed by the lipid A and the inner and outer core oligosaccharides ([@B39]). While the inner core oligosaccharide is well conserved, the outer core is highly variable ([@B22]). The group of genes coding for the outer core oligosaccharide are known as the OC locus. The surface carbohydrates have been linked to the virulence of *A. baumannii* in numerous studies ([@B68]; [@B35]; [@B28]). We found the *A. baumannii* A118 K locus structure located between the *fkpA* and *lldP* genes as it has been reported for other strains ([@B38]). Nucleotide sequence comparison of this locus showed 99% identity (100% cover) with that of the strain Sv8/PSgc8 described by [@B32]; ([Figure 4A](#F4){ref-type="fig"}). A search to identify the OC locus showed that an *A. baumannii* A118 gene cluster exhibited 98% identity (79% cover) with those present in strains D46, ZW85-1, and 6200 ([Figure 4B](#F4){ref-type="fig"}). None of the reported versions of the OC locus was identical to that of the *A. baumannii* A118 strain. The two genes not represented in strain D46 show 100% amino acid sequence identity with those found in strain Naval-72. On the other hand, the *rmlB*, *rmlD*, *rmlA* y *rmlC* genes present in this locus in strain D46 are located in the K locus in *A. baumannii* A118 (see [Figures 4A,B](#F4){ref-type="fig"}). According to the OC loci classification proposed by [@B39], the *A. baumannii* A118 OC locus belongs to group B.

![K and OC loci comparisons. **(A)** Comparison of the K loci from *A. baumannii* strains A118 and PSgc8 (Accession Number [LUH5538](LUH5538)). Comparison was performed using BLAST (version 2.2.31) and the graphic representation was generated using the software EasyFig (version 2.1). Proteins coded for by the genes are: *wzc*, Tyrosine-protein kinase; *wzb*, protein-tyrosine-phosphatase; *wza*, periplasmic protein; *gnaA*, UDP-glucose/GDP-mannose dehydrogenase; *rmlB*, dTDP-D-glucose-4,6-dehydratase; *rmlD*, dTDP-4-dehydrorhamnose reductase; *rmlA*, dTDP-glucose pyrophosphorylase; *rmlC*, dTDP-4-keto-6-deoxy-D-glucose-3,5-epimerase; *wzx*, flippase; *wafX*, glycosyltransferase; *wzy*, O antigen polymerase; *wafY*, glycosyltransferase; *wafZ*, glycosyltransferase; *wagA*, acetyltransferase; *gnaB*, NAD-dependent epimerase/dehydratase; *wagB*, glycosyl transferase; *weeH*, glycosyltransferase; *galU*, UDP-glucose pyrophosphorylase; *ugd*, UDP-glucose 6-dehydrogenase; *gpi*, glucose-6-phosphate isomerase; *cgmA*, cyclic beta-1,2-glucan modification transmembrane protein; *pgm*, phosphoglucomutase; *lldP*, L-lactate permease. **(B)** Comparison of the OC loci from *A. baumannii* strains A118 and D46 (Accession Number [KF030679](KF030679)). All three strains, D46, ZW85-1 (Accession Number [CP006768](CP006768)), and 6200 (Accession Number [CP010397](CP010397)), have identical OC loci. Proteins coded for by the genes are: *gtrOC1*, glycosyltransferase; *pda2*, polysaccharide deacetylase; *gtrOC18*, glycosyltransferase; *gtrOC19*, glycosyltransferase; *gtrOC20*, glycosyltransferase; *gtrOC21*, glycosyltransferase; *gtrOC_A118_1*, capsular protein, polysaccharide synthesis; *gtrOC_A118_2*, glycosyltransferase.](fmicb-10-01599-g004){#F4}

Experimental Infections {#S3.SS5}
-----------------------

The virulence of *A. baumannii* A118 was assessed using the *G. mellonella* model of infection. [Figure 5](#F5){ref-type="fig"} shows that larvae infections with this strain results in a significant increase in mortality as compared to the negative control. However, strain A118 showed lower virulence when compared to the *A. baumannii* ATCC 17978 and ATCC 19606T strains, both of which produced comparable larvae survival rates ([Figure 5](#F5){ref-type="fig"}).

![*Galleria mellonella* infection assays. Infections were carried out as described in Materials and Methods. Larvae were injected with 1 × 10^5^ cells of *A. baumannii* A118, 19606^T^, or 17978 resuspended in sterile PBS. Negative controls were injected with PBS.](fmicb-10-01599-g005){#F5}

Concluding Remarks {#S4}
==================

There is an urgent need to find answers to the problem of infections with bacteria belonging to the ESKAPE group ([@B8]), which includes *A. baumannii*. Research on this bacterium presents numerous challenges due to its tremendous genetic plasticity and diversity, as well as its multiresistance to most antibiotics used for selection in the molecular biology laboratory ([@B63]; [@B78]; [@B73]). We have analyzed functions related to the antibiotic resistance/susceptibility profile of the model strain *A. baumannii* A118 ([@B63], [@B62]). Building on the characterization of this strain we show here the presence of genetic and cellular traits that could be associated to its pathogenicity. It most probably includes at least two iron uptake systems, those mediated by the siderophores acinetobactin and baumannoferrin ([@B17], [@B18]; [@B50]; [@B20]). The presence of the *csu* operon is compatible with the ability of *A. baumannii* A118 to form biofilms on polystyrene and glass to levels comparable to strain ATCC 19606^T^. The K and OC loci were identified and characterized, while the K locus has been found in another isolated, the OC locus was still undescribed. Although *A. baumannii* A118 displayed more surface motility than ATCC 19606^T^ under all tested conditions, its motility seems reduced when compared to ATCC17978, particularly under illumination at 37°C. This response could be due to the absence of the gene coding for a fimbrial protein that might be involved in this response. In conclusion, *A. baumannii* A118 possesses the main potential virulence factors found in other clinical isolates reinforcing the usefulness of this strain as a model of genetic manipulation and pathogenic studies.
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